Skip to content

To study the Effects of Homoeopathic Medicines in the Treatment of Migraine Among Adults

Effectiveness of Individualization in Homoeopathic Management of Migraine Among Adults an Experimental Non Controlled Study - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/10/095879
Enrollment
36
Registered
2025-10-10
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G439- Migraine, unspecified

Interventions

Intervention1: Homoeopathic Management with respect to Individualization: According to the Requirement of the patients health Homoeopathic Medicine in the Form of Pills orally will be Prescribed Durin

Sponsors

Dr Nihar Patil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Clinically pre diagnosed patients of Migraine with Aura and Migraine without Aura Patients of Migraine of adult age group from 20- 50 years Patients of Migraine of all genders

Exclusion criteria

Exclusion criteria: Patients of Chronic Migraine Basilar Migraine Vestibular Migraine Patients of Migraine with complications of Migraine such as Status Migrainosus Migrainous Infarction Migralepsy Patients of Migraine with neurological symptoms such as Vertigo Paresthesia Dysarthria Patients of Migraine taking medication within one month of start of treatment Suspected Immunocompromised patients Pregnant and Lactating females

Design outcomes

Primary

MeasureTime frame
Outcome will be Assessed in Terms of 1 Improved 2 Not Improved These Criteria will be Assessed as Per the Score of MIDAS ScaleTimepoint: 1 Duration of Study - 18 Months 2 Duration of each case: Each case will be studied for 9 months. 3. Duration of Follow up: Each case will be followed up at the interval of 15 days or earlier, if required. 4. Statistical outcome assessment will be done at the baseline, 3 months, 6 months, 9 months i.e. 3 months after conclusion of the treatment.

Secondary

MeasureTime frame
Not ApplicableTimepoint: Not Applicable

Countries

India

Contacts

Public ContactDr Chintan Mehta

Dr G D Pol Foundation YMT Homoeopathic Medical College and PG Institute

snehom5@gmail.com9322506976

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026